Fund Holdings — MPM ASSET MANAGEMENT LLC

Total Portfolio Value:
$124.40M
Total Bought:
$0
Total Sold:
$10.53M
Net Transaction:
-$10.53M
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Entrada Therapeutics, Inc.(TRDA)4,425,7844,381,062-44,722$70.72M$75.75M60.89%+$5.02M
iTeos Therapeutics, Inc.2,738,7852,738,7850$27.96M$21.03M16.91%-$6.93M
Dyne Therapeutics, Inc.(DYN)682,376682,3760$24.51M$16.08M12.92%-$8.43M
Werewolf Therapeutics, Inc.(HOWL)4,284,1724,284,1720$9.08M$6.34M5.10%-$2.74M
Adaptimmune Therapeutics plcADR(ADAPY)5,555,4615,555,4610$5.28M$2.99M2.41%-$2.28M
Repare Therapeutics, Inc.2,242,6361,683,707-558,929$7.71M$2.21M1.77%-$5.51M
Page 1 of 1
MPM ASSET MANAGEMENT LLC — 13F Holdings — Q4 2024 | TickerTrail